Low Progesterone in Pregnancy: Treatment Options

If you have been told your progesterone level is low in early pregnancy, it is natural to want to know whether treatment is available and whether it can help. This guide explains when low progesterone is treated in the UK, what the evidence shows, and what the treatment experience actually looks like day to day.

What Progesterone Does in Early Pregnancy
When Low Progesterone Is Treated
What Treatment Looks Like in Practice
Understanding the Limits of Treatment
Frequently Asked Questions

What Progesterone Does in Early Pregnancy

Progesterone is a hormone produced first by the corpus luteum — the structure left behind in the ovary after the egg is released — and later by the placenta. In early pregnancy it plays a crucial role in preparing and maintaining the uterine lining, suppressing uterine contractions that might otherwise dislodge the implanting embryo, and supporting the development of a healthy placenta.

Levels of progesterone rise throughout the first trimester and, by around ten to twelve weeks, the placenta takes over production from the corpus luteum in a process called the luteo-placental shift. This is why progesterone supplementation, when it is used, is typically continued only until around twelve to sixteen weeks.

A single low progesterone reading can be difficult to interpret. Progesterone levels fluctuate throughout the day and can vary between laboratories. A low level does not always mean the pregnancy is failing — but it can be a marker that something is not developing as expected. Your clinical team will look at progesterone alongside hCG levels and ultrasound findings rather than treating any single number in isolation.

When Low Progesterone Is Treated

Progesterone treatment is not automatically offered for every low reading, because a low level often reflects a pregnancy that is already failing rather than being the cause of the problem. Prescribing progesterone to a pregnancy that is failing for another reason — most commonly chromosomal — will not change the outcome.

However, there are specific circumstances where progesterone treatment is recommended in the UK:

Bleeding in early pregnancy with a history of miscarriage: The landmark PRISM trial, a large UK randomised controlled trial, found that progesterone pessaries improved the live birth rate in women who were bleeding in early pregnancy and had experienced one or more previous miscarriages. This is now reflected in RCOG and NICE guidance, and many early pregnancy units in England offer progesterone on this basis.

Assisted conception pregnancies: Women who have conceived through IVF or other assisted reproductive techniques are routinely given progesterone supplementation as part of their protocol, because the natural corpus luteum may not produce sufficient levels following egg retrieval and embryo transfer.

Recurrent miscarriage with a luteal phase defect: In some women with a documented pattern of recurrent pregnancy loss and evidence of poor luteal function, progesterone support may be offered from the point of a positive pregnancy test.

History of preterm birth: Progesterone (in a different form, often cervical gel or injection) is used in some cases to reduce the risk of preterm birth, particularly in women with a short cervix identified on scan.

If you have had a low progesterone reading without any of these risk factors, your team may monitor you closely rather than starting treatment immediately — this is appropriate clinical practice, not neglect.

What Treatment Looks Like in Practice

If your clinical team decides you meet the criteria for progesterone supplementation, treatment in the UK most commonly takes one of these forms:

Vaginal pessaries or capsules are the most frequently prescribed option. Brands you may be offered include Cyclogest (a pessary) or Utrogestan (a soft capsule that can be used vaginally). These are inserted into the vagina once or twice daily, usually in the morning and evening. They are absorbed directly through the vaginal mucosa, which means the concentration reaching the uterus is higher than with oral tablets, while systemic side effects tend to be lower.

Intramuscular injections of progesterone in oil are used in some specialist fertility and early pregnancy settings, particularly following IVF cycles. They are less common in standard NHS early pregnancy care but may be appropriate in specific clinical situations.

Treatment typically begins as soon as the decision is made — either at the point of confirmed bleeding, a positive pregnancy test in a monitored cycle, or when a low progesterone is identified — and continues until twelve to sixteen weeks, when the placenta is producing sufficient progesterone independently.

Common side effects include increased vaginal discharge (which is the pessary dissolving), mild bloating, breast tenderness, and in some women, drowsiness if using Utrogestan orally. Most side effects are mild and do not require stopping treatment. If you develop itching, rash, or unusual symptoms, mention them to your prescribing team.

Your team will usually arrange at least one follow-up scan to confirm the pregnancy is continuing before extending the prescription beyond the initial period.

Understanding the Limits of Treatment

It is important to approach progesterone treatment with realistic expectations. The evidence supports its use in specific situations — particularly bleeding with a heartbeat and a history of miscarriage — but it is not a guarantee of a healthy outcome, and it cannot reverse a miscarriage that is already in progress for chromosomal reasons.

The majority of early pregnancy losses in the general population are caused by chromosomal abnormalities in the embryo. These occur at the point of fertilisation and cannot be prevented or reversed by any hormone treatment. In these cases, low progesterone is a consequence of the failing pregnancy rather than its cause.

If you are offered progesterone and later miscarry despite taking it, this does not mean the treatment failed or that you did anything wrong. It means the pregnancy had a cause of loss that progesterone could not address. This is an important distinction that many people find helpful to understand, even though it does not make the loss any easier.

If you are not offered progesterone and feel you have questions about why, it is reasonable to ask your early pregnancy unit or consultant to explain their reasoning. Shared decision-making is part of good antenatal care.

Frequently Asked Questions

Can progesterone save a failing pregnancy?

Only in specific situations. If a pregnancy is failing because of chromosomal abnormalities — the most common cause of early miscarriage — progesterone will not change the outcome. Where treatment has shown benefit is in women who are bleeding in early pregnancy, have a confirmed heartbeat on scan, and have a history of one or more previous miscarriages. In those circumstances, UK trial evidence supports progesterone as improving the chance of a live birth.

Are progesterone pessaries safe for the baby?

Progesterone used in early pregnancy is considered safe. The PRISM trial, which involved thousands of women in UK hospitals, found no significant increase in harm to babies born to women who received progesterone treatment compared to those who did not. Progesterone is a naturally occurring hormone and the forms used in pregnancy have been studied over many years in the context of IVF and other treatments.

Do I need a prescription for progesterone in the UK?

Yes. Progesterone pessaries, capsules, and injections are prescription-only medicines in the UK. You cannot buy them over the counter. If you believe you meet the criteria for treatment — particularly if you have bleeding in early pregnancy and a history of miscarriage — ask your GP, early pregnancy unit, or fertility clinic to assess you. They can prescribe progesterone if you meet the clinical criteria under current NICE-aligned guidance.

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your midwife, GP, or obstetrician about your individual results and care plan.

Further reading:

NHS — Antenatal care and screening